- Conditions
- Type 1 Diabetes
- Interventions
- Closed loop with sensor and Insulin, Closed loop with sensor, Insulin and Liraglutide
- Drug
- Lead sponsor
- Albert Einstein College of Medicine
- Other
- Eligibility
- 18 Years to 40 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 1
- States / cities
- The Bronx, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1177–1200
of 1,477
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Type 1 Diabetes, Pregnancy in Diabetic
- Interventions
- Not listed
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 0 Days to 99 Years
- Enrollment
- 6,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2032
- U.S. locations
- 4
- States / cities
- Aurora, Colorado • Boston, Massachusetts • New York, New York + 1 more
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Hypo-Hyper Minimizer (HHM) System
- Device
- Lead sponsor
- Animas Corporation
- Industry
- Eligibility
- 21 Years to 65 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012
- U.S. locations
- 2
- States / cities
- Santa Barbara, California • Charlottesville, Virginia
- Conditions
- Type 1 Diabetes
- Interventions
- Resistance Training
- Other
- Lead sponsor
- University of Louisville
- Other
- Eligibility
- 13 Years to 17 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 2
- States / cities
- Louisville, Kentucky
- Conditions
- Type 1 Diabetes, Celiac Disease
- Interventions
- Blood Draw
- Other
- Lead sponsor
- AdventHealth Translational Research Institute
- Other
- Eligibility
- 2 Years and older
- Enrollment
- 115 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Orlando, Florida
- Conditions
- New-onset Type 1 Diabetes
- Interventions
- Ladarixin, Placebo
- Drug · Other
- Lead sponsor
- Dompé Farmaceutici S.p.A
- Industry
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 2
- States / cities
- Aurora, Colorado • Atlanta, Georgia
- Conditions
- Type1 Diabetes
- Interventions
- Zone-Model Predictive Control Artificial Pancreas (ZMPC_AP)
- Device
- Lead sponsor
- Yale University
- Other
- Eligibility
- 2 Years to 18 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Not listed
- Lead sponsor
- Rodolfo Alejandro
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2028
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Type 1 Diabetes, Type 2 Diabetes
- Interventions
- Breaking Down Barriers
- Behavioral
- Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NIH
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 222 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2007
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- LY900014, Insulin Lispro, Insulin Glargine, Insulin Degludec
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 1 Year to 17 Years
- Enrollment
- 751 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 27
- States / cities
- Birmingham, Alabama • Tucson, Arizona • Los Angeles, California + 24 more
- Conditions
- Type1 Diabetes Mellitus
- Interventions
- CL/AP system, usual diabetic care
- Device
- Lead sponsor
- Yale University
- Other
- Eligibility
- 50 Years to 75 Years
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Diabetes Mellitus
- Interventions
- insulin glargine, insulin glulisine
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 21 Years to 70 Years
- Enrollment
- 582 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 1
- States / cities
- Milwaukee, Wisconsin
- Conditions
- Type I Diabetes
- Interventions
- Placebo GABA and Placebo GAD-alum, GABA and Placebo GAD-alum, Active Oral GABA and Active GAD-alum injection
- Drug
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 4 Years to 18 Years
- Enrollment
- 101 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2022
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Automatic closed-loop insulin delivery, Control
- Device
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 14 Years to 40 Years
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014
- U.S. locations
- 3
- States / cities
- Angelus Oaks, California • Mountain View, California • Palo Alto, California
- Conditions
- Insulin Response, Type 1 Diabetes
- Interventions
- Standardized meal 1
- Other
- Lead sponsor
- Texas A&M University
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 32 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- College Station, Texas
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- interferon alpha
- Drug
- Lead sponsor
- National Center for Research Resources (NCRR)
- NIH
- Eligibility
- 3 Years to 25 Years
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Overnight CLC, Sensor-Augmented Pump Therapy (SAP)
- Device
- Lead sponsor
- Sue Brown
- Other
- Eligibility
- 21 Years to 64 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 1
- States / cities
- Charlottesville, Virginia
- Conditions
- Diabetes Mellitus, Type 1, Autoimmune Diseases, Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, Immune System Diseases, Metabolic Diseases
- Interventions
- Glutamine vs. Placebo, Exercise
- Drug · Behavioral
- Lead sponsor
- Nemours Children's Clinic
- Other
- Eligibility
- 13 Years to 19 Years
- Enrollment
- 14 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 1
- States / cities
- Jacksonville, Florida
- Conditions
- Type 1 Diabetes
- Interventions
- Simple Meal Bolusing, Carbohydrate counting
- Behavioral
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 14 Years to 26 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 1
- States / cities
- Aurora, Colorado
- Conditions
- Type 1 Diabetes
- Interventions
- MiniMed 780G System
- Device
- Lead sponsor
- Medtronic MiniMed, Inc.
- Industry
- Eligibility
- 7 Years to 80 Years
- Enrollment
- 240 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 15
- States / cities
- Little Rock, Arkansas • Fresno, California • Sacramento, California + 12 more
- Conditions
- Type 1 Diabetes
- Interventions
- Transition Social Behavioral Intervention, Diabetes Transition Clinic
- Behavioral
- Lead sponsor
- University of Kansas
- Other
- Eligibility
- 16 Years to 29 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 1
- States / cities
- Kansas City, Kansas
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Insulin Degludec, Insulin Glargine, TRESIBA® FLEXTOUCH®, LANTUS® SOLOSTAR® INSULIN PEN
- Drug · Device
- Lead sponsor
- Sansum Diabetes Research Institute
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 2
- States / cities
- Santa Barbara, California • Honolulu, Hawaii
- Conditions
- Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
- Interventions
- MiniMed™ NMX8-AID System with DS5™/Simplera Sync™
- Device
- Lead sponsor
- Medtronic MiniMed, Inc.
- Industry
- Eligibility
- 7 Years to 85 Years
- Enrollment
- 389 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 29
- States / cities
- Little Rock, Arkansas • Escondido, California • Goleta, California + 25 more
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Glargine, LY2605541, Insulin Lispro
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,114 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 47
- States / cities
- Concord, California • Fresno, California • La Mesa, California + 44 more